Nasdaq

BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes

FRANKLIN LAKES, N.J., Sept. 30, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 ...
Nasdaq

BD (BDX), ImageMover Partner for Rapid Antigen Test Reporting

Becton, Dickinson and Company BDX, popularly known as BD, recently collaborated with ImageMover to provide a companion mobile app that will aid in a smoother running of SARS-CoV-2 antigen testing ...
News Medical

BD launches new, wireless rapid diagnostic system for detection of flu, RSV and group A strep

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of influenza A and B, ...
NJBIZ

FDA grants emergency use authorization for BD’s 15-minute COVID antigen test

Becton, Dickinson and Co. said Monday it was granted emergency use authorization from the U.S. Food and Drug Administration (FDA) for a COVID-19 antigen test that can be administered at the point of ...
The Motley Fool

FDA Authorizes Becton, Dickinson Portable 15-Minute Coronavirus Test

The test is based on the company's BD Veritor Plus System, a handheld diagnostic device. The test is used in combination with the company's BD Veritor Plus System, a handheld electronic diagnostic ...
Pharmabiz

BD gets order from Dutch Ministry of Health for 9.2 mn 15-minute COVID-19 antigen tests for use on BD Veritor Plus System

BD (Becton, Dickinson and Company), a leading global medical technology company, announced the receipt of an order from the Dutch Ministry of Health for 9.2 million of its rapid, point-of-care, ...
abc27

BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test

FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug ...
FierceBiotech

BD launches 15-minute coronavirus antigen test, promises millions in coming months

The FDA granted an emergency authorization to a portable coronavirus antigen test developed by BD, similar to a rapid flu test, designed to allow hospitals, doctors' offices, urgent care centers and ...
Business Insider

BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes

SARS-CoV-2 Assay for BD Veritor™ Plus System to be available in Europe by end of October FRANKLIN LAKES, New Jersey, Sept. 30, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a ...
Seeking Alpha

BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test

New CLIA-Waived Test Delivers Digital Results to Support Timely Clinical Decision-Making FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global ...
Pharmabiz

BD receives CE marking of portable, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes

BD (Becton, Dickinson and Company), a leading global medical technology company, announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor plus System has been CE marked to ...